XYOSTED (AUTOINJECTOR)

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Sep 28, 2018

   7 yr 10 mo ago

2. Patent 10478560 expires

   Listed drug product patent expiration.

   Jan 24, 2026

   5 mo ago

3. Patent 11446441 expires

   Listed drug product patent expiration.

   Jan 24, 2026

   5 mo ago

4. Patent 8562564 expires

   Listed drug product patent expiration.

   Jan 24, 2026

   5 mo ago

5. Patent 9180259 expires

   Listed drug product patent expiration.

   Jan 24, 2026

   5 mo ago

6. Patent 9533102 expires

   Listed drug product patent expiration.

   Jan 24, 2026

   5 mo ago

7. Patent 9629959 expires

   Listed drug product patent expiration.

   Jan 24, 2026

   5 mo ago

8. Today

9. Patent 8021335 expires

   Listed drug product patent expiration.

   Oct 04, 2026

   in 4 mo

10. Patent 11497753 expires

    Listed drug product patent expiration.

    Mar 19, 2030

    in 3 yr 10 mo

11. Patent 10279131 expires

    Listed drug product patent expiration.

    Jul 31, 2031

    in 5 yr 2 mo

12. Patent 10357609 expires

    Listed drug product patent expiration.

    Aug 21, 2031

    in 5 yr 3 mo

13. Patent 10905827 expires

    Listed drug product patent expiration.

    Aug 21, 2031

    in 5 yr 3 mo

14. Patent 11446440 expires

    Listed drug product patent expiration.

    Aug 21, 2031

    in 5 yr 3 mo

15. Patent 10821072 expires

    Listed drug product patent expiration.

    Jun 04, 2033

    in 7 yr 1 mo

16. Patent 11844804 expires

    Listed method-of-use patent (U-2418) expiration.

    Jun 04, 2033

    in 7 yr 1 mo

17. Patent 10881798 expires

    Listed drug product patent expiration.

    Feb 11, 2034

    in 7 yr 9 mo

18. Patent 11160751 expires

    Listed drug product patent expiration.

    Oct 07, 2034

    in 8 yr 5 mo

19. Patent 10238662 expires

    Listed drug product patent expiration.

    Feb 19, 2035

    in 8 yr 10 mo

20. Patent 10912782 expires

    Listed drug product patent expiration.

    Feb 19, 2035

    in 8 yr 10 mo

21. Patent 11813435 expires

    Listed drug product patent expiration.

    Feb 25, 2035

    in 8 yr 10 mo

22. Patent 12629483 expires

    Listed drug product patent expiration.

    Aug 07, 2035

    in 9 yr 3 mo

23. Patent 11191908 expires

    Listed drug product patent expiration.

    Oct 18, 2035

    in 9 yr 6 mo

24. Patent 9744302 expires

    Listed drug product patent expiration.

    Nov 19, 2035

    in 9 yr 7 mo

25. Patent 9950125 expires

    Listed drug product patent expiration.

    Sep 04, 2036

    in 10 yr 4 mo

26. Patent 10646495 expires

    Listed drug product patent expiration.

    Aug 30, 2038

    in 12 yr 5 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

• DELATESTRYLBrand (NDA)

  NDA 009165 · ENDO PHARMS

  —
• TESTOSTERONE ENANTHATEGeneric (ANDA)

  ANDA 212659 · EUGIA PHARMA

  2024
• TESTOSTERONE ENANTHATEGeneric (ANDA)

  ANDA 091120 · HIKMA FARMACEUTICA

  2012
• TESTOSTERONE ENANTHATEGeneric (ANDA)

  ANDA 040647 · RISING

  2009
• TESTOSTERONE ENANTHATEGeneric (ANDA)

  ANDA 040575 · NEXUS

  2006
• TESTOSTERONE ENANTHATEGeneric (ANDA)

  ANDA 083667 · WATSON LABS

  —
• TESTOSTERONE ENANTHATEGeneric (ANDA)

  ANDA 085599 · WATSON LABS

  —
• TESTOSTERONE ENANTHATEGeneric (ANDA)

  ANDA 085598 · WATSON PHARMS INC

  —

Listed patents (24)